Immune Pharmaceuticals Inc Bankrupt Revenue, Growth & Competitor Profile

DBA EPICEPT CORPORATION
DBA IMMUNE PHARMACEUTICALS INC

Company Profile & Annual Report for Immune Pharmaceuticals Inc Bankrupt

Access the complete profile.

Immune Pharmaceuticals Inc Bankrupt Fast Facts

Revenue	Less than $1 million    See Exact Annual Revenue
Employees	N/AExact Company Size
Primary Industry	5417 Scientific Research & Development Services
Address	C/o Jeffrey Lester Esq. Ttee 374 Main St Hackensack, NJ 07601

Note: Revenues for privately held companies are statistical evaluations.


Immune Pharmaceuticals Inc Bankrupt's Annual Report & Profile shows critical firmographic facts:

• What is the company's size? (Annual sales and employees)
  • Immune Pharmaceuticals Inc Bankrupt's annual revenues are Less than $1 million (see exact revenue data)
• What industry is the company in?
  • Immune Pharmaceuticals Inc Bankrupt is classified as operating in the Scientific Research & Development Services industry, NAICS Code 5417.

Immune Pharmaceuticals Inc Bankrupt Annual Revenue and Growth Rate

Immune Pharmaceuticals Inc Bankrupt	Revenue Est. ($ Million)	Growth Rate (%)	# Employees
2025	Less than $1 million Details in Premium Report
2024
2023
2021
2020
2019

1-Year Growth Rate: 3-Year Growth Rate (CAGR):

Note: Immune Pharmaceuticals Inc Bankrupt's revenues are gauged from an analysis of company filings.

Immune Pharmaceuticals Inc Bankrupt's Income Statement (based on Industry Averages)

Immune Pharmaceuticals Inc Bankrupt P&L	$ Millions
Revenue (Sales)
Cost of Goods Sold
Gross Profit
Operating Expenses
Advertising
Salaries and wages
Other Operating Expenses
Total Operating Expenses
Operating Income
EBITDA
EBIT (Earnings Before Interest and Taxes)
Net Profit

Trademark Applications

Trademark applications show the products and services that Immune Pharmaceuticals Inc Bankrupt is developing and marketing. Immune Pharmaceuticals Inc Bankrupt doesn't have any recent trademark applications, indicating Immune Pharmaceuticals Inc Bankrupt is focusing on its existing business rather than expanding into new products and markets. Trademarks may include brand names, product names, logos and slogans.

Trademark	Date
AMIKET Topical analgesics	04/28/2011
CROLIBULIN Pharmaceutical preparation for the treatment of cancer	04/08/2010
LIDOPAIN MEDICATED TOPICAL PATCH FOR USE IN THE THERAPEUTIC AND PROPHYLACTIC TREATMENT OF PAIN, INFLAMMATION, TRAUMA, WOUNDS, BURNS AND INFECTIONS	02/15/2005

See all trademarks and details in the Full Report.

Market Share of Immune Pharmaceuticals Inc Bankrupt's Largest Competitors

A competitive analysis shows these companies are in the same general field as Immune Pharmaceuticals Inc Bankrupt, even though they may not compete head-to-head. These are the largest companies by revenue. However, they may not have the largest market share in this industry if they have diversified into other business lines. The "Competition" section of a business plan or investment memorandum would start by analyzing the information about these companies. Competitive advantage comes from offering better pricing or superior products/service.

Company	Headquarters	Revenue ($ MM)
LEIDOS	Denver, CO	100
NATIONAL TECHNOLOGY & ENGINEERING SOLUTIONS OF SANDIA	Albuquerque, NM	30
INC RESEARCH	Raleigh, NC	27
RESEARCH FOUNDATION FOR STATE UNIVERSITY OF NEW YORK	Albany, NY	17
FLUOR MARINE PROPULSION	West Mifflin, PA	15
SYNEOS HEALTH	Raleigh, NC	13
ILLUMINA	San Diego, CA	12
UT-BATTELLE	Oak Ridge, TN	11
PRA HOLDINGS	Raleigh, NC	11

Nearby Competitors

These companies are similar in business line and location to Immune Pharmaceuticals Inc Bankrupt. While some companies compete with neighboring businesses for customers, other companies may compete to attract skilled employees.

Company	Headquarters	Revenue ($ MM)
CHAMPIONS ONCOLOGY	Hackensack, NJ	100
PSYCHOGENICS	Paramus, NJ	97
XOGENE SERVICES	Englewood, NJ	33
RESEARCH INSTITUE FOR FRAGRANCE MATERIALS	Woodcliff Lake, NJ	30
Q_PERIOR	Saddle Brook, NJ	10
WETLANDSINC.	Saddle Brook, NJ	6

Future Competition: Immune Pharmaceuticals Inc Bankrupt's Fastest Growing Competitors

These companies are in the same general field as Immune Pharmaceuticals Inc Bankrupt and are rapidly expanding. Companies may grow organically or through acquisition. In some cases apparently high growth rates may be caused by data that weren't available in previous years.

Company	Revenue ($ MM)